Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wataru Okamoto

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
ACS Omega|July 3, 2023
Pharmaceutical Integrity of Lyophilized Methemoglobin-Albumin Clusters after ReconstitutionYuto Suzuki, Kazuaki Taguchi, Wataru Okamoto, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 23, 2023
Zinc Substituted Myoglobin-Albumin Fusion Protein: A Photosensitizer for Cancer TherapyTaiga Yamada, Yoshitsugu Morita, Ryoya Takada, et al.
Internal Medicine (Tokyo, Japan)|March 1, 2023
Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung CancerMasahiko Sumii, Masashi Namba, Kentaro Tokumo, et al.
Cancer Science|September 12, 2021
SCRUM-Japan GI-SCREEN and MONSTAR-SCREEN: Path to the realization of biomarker-guided precision oncology in advanced solid tumorsYoshiaki Nakamura, Takao Fujisawa, Hiroya Taniguchi, et al.
Investigational New Drugs|May 26, 2011
Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancerTaroh Satoh, Kensei Yamaguchi, Narikazu Boku, et al.
Case Reports in Oncology|December 13, 2021
Conversion from Positive to Negative EGFR Mutation due to Clonal Selection during Long-Term Treatment with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Case ReportMasatomo Ueda, Masashi Namba, Kentaro Tokumo, et al.
ACS Applied Bio Materials|February 13, 2025
Nanoparticle O<sub>2</sub> Carrier Composed of a Polymerized Stroma-Free Hemoglobin Core and Serum Albumin Shell as a Red Blood Cell Alternative in Hemorrhagic Shock TherapyNatsumi Kohyama, Koki Takamine, Wataru Okamoto, et al.
Investigational New Drugs|May 31, 2014
Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: phase i study in Japanese patients with advanced solid malignancies and advanced breast cancerTakayasu Kurata, Junji Tsurutani, Yasuhito Fujisaka, et al.
Brain Research|September 25, 2023
Neuroprotective effects of a hemoglobin-based oxygen carrier (stroma-free hemoglobin nanoparticle) on ischemia reperfusion injuryRyota Tatezawa, Takeo Abumiya, Yasuhiro Ito, et al.
Anticancer Research|May 18, 2012
Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalinHiromichi Matsuoka, Chihiro Makimura, Atsuko Koyama, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
ACS Omega|July 3, 2023
Pharmaceutical Integrity of Lyophilized Methemoglobin-Albumin Clusters after ReconstitutionYuto Suzuki, Kazuaki Taguchi, Wataru Okamoto, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 23, 2023
Zinc Substituted Myoglobin-Albumin Fusion Protein: A Photosensitizer for Cancer TherapyTaiga Yamada, Yoshitsugu Morita, Ryoya Takada, et al.
Internal Medicine (Tokyo, Japan)|March 1, 2023
Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung CancerMasahiko Sumii, Masashi Namba, Kentaro Tokumo, et al.
Cancer Science|September 12, 2021
SCRUM-Japan GI-SCREEN and MONSTAR-SCREEN: Path to the realization of biomarker-guided precision oncology in advanced solid tumorsYoshiaki Nakamura, Takao Fujisawa, Hiroya Taniguchi, et al.
Investigational New Drugs|May 26, 2011
Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancerTaroh Satoh, Kensei Yamaguchi, Narikazu Boku, et al.
Case Reports in Oncology|December 13, 2021
Conversion from Positive to Negative EGFR Mutation due to Clonal Selection during Long-Term Treatment with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Case ReportMasatomo Ueda, Masashi Namba, Kentaro Tokumo, et al.
ACS Applied Bio Materials|February 13, 2025
Nanoparticle O<sub>2</sub> Carrier Composed of a Polymerized Stroma-Free Hemoglobin Core and Serum Albumin Shell as a Red Blood Cell Alternative in Hemorrhagic Shock TherapyNatsumi Kohyama, Koki Takamine, Wataru Okamoto, et al.
Investigational New Drugs|May 31, 2014
Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: phase i study in Japanese patients with advanced solid malignancies and advanced breast cancerTakayasu Kurata, Junji Tsurutani, Yasuhito Fujisaka, et al.
Brain Research|September 25, 2023
Neuroprotective effects of a hemoglobin-based oxygen carrier (stroma-free hemoglobin nanoparticle) on ischemia reperfusion injuryRyota Tatezawa, Takeo Abumiya, Yasuhiro Ito, et al.
Anticancer Research|May 18, 2012
Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalinHiromichi Matsuoka, Chihiro Makimura, Atsuko Koyama, et al.
Pageof 10